This is an intriguing point, as IL-1β is emerging as a critical player in several obesity-related comorbidities (i.e., insulin resistance, meta-inflammatory condition, cardiovascular diseases) [48,49], and thus the enteric glia could participate in the maintenance of such disorders. Here, IL1B is linked to cardiovascular disorder.